Modulation of murine macrophage function by N-acetylcysteine in a model of endotoxic shock

被引:29
作者
Víctor, VM [1 ]
Guayerbas, N [1 ]
Garrote, D [1 ]
Del Río, M [1 ]
De la Fuente, M [1 ]
机构
[1] Univ Complutense Madrid, Fac Biol Sci, Dept Anim Physiol, E-28040 Madrid, Spain
关键词
N-acetylcysteine; macrophages; phagocytic function; LPS; endotoxic shock;
D O I
10.1002/biof.5520100405
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In previous studies we have observed changes in several functions of peritoneal macrophages from BALB/c mice with irreversible endotoxic shock caused by intraperitoneal injection of E. coli lipopolysaccharide (LPS) (100 mg/kg), which were associated with a high production of superoxide anion. Since antioxidants, such as N-acetylcysteine (NAC), are free radical scavengers that improve the immune response, in the present work we have studied different functions of peritoneal macrophages from BALB/c mice suffering the endotoxic shock above indicated and administered N-acetylcysteine (150 mg/kg i.p.) at 30 minutes after LPS injection. In the peritoneal macrophages obtained at 2, 4, 12 and 24 h after LPS injection, the following functions were studied: adherence to substrate, mobility, ingestion of particles, and production of superoxide anion and tumour necrosis factor (TNF alpha). The increase in adherence, ingestion and superoxide anion and TNF alpha production shown by macrophages from animals with endotoxic shock was counteracted by NAC injection. Moreover, the survival time of mice with endotoxic shock was increased in the presence of NAG. These data suggest that NAG, administered intraperitoneally, may be useful for the treatment of irreversible endotoxic shock by modulation of the function of macrophages with decreased superoxide anion and TNF alpha production and concomitant increase of survival time.
引用
收藏
页码:347 / 357
页数:11
相关论文
共 46 条
[1]  
AYALA A, 1996, SHOCK, V6, P527
[2]  
BAGASRA O, 1988, IMMUNOLOGY, V65, P405
[3]   EFFECTS OF N-ACETYLCYSTEINE IN ENDOTOXIC-SHOCK [J].
BAKKER, J ;
ZHANG, HB ;
DEPIERREUX, M ;
VANASBECK, S ;
VINCENT, JL .
JOURNAL OF CRITICAL CARE, 1994, 9 (04) :236-243
[4]  
BAUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141
[5]  
BERNARD GR, 1991, AM J MED S3C, V91, P54
[6]  
BOYDEN SV, 1962, J EXP MED, V11, P1690
[7]  
BREVIARIO F, 1988, J IMMUNOL, V141, P2291
[8]   Macrophage migration inhibitory factor (MIF): A glucocorticoid counter-regulator within the immune system [J].
Calandra, T ;
Bucala, R .
CRITICAL REVIEWS IN IMMUNOLOGY, 1997, 17 (01) :77-88
[9]  
CALANDRA T, 1994, DIAGN MICROBIOL INFE, V13, P377
[10]   Evidence for tumor necrosis factor alpha as a mediator of the toxicity of a cyclooxygenase inhibitor in Gram-negative sepsis [J].
Campanile, F ;
Giampietri, A ;
Grohmann, U ;
Belladonna, ML ;
Fioretti, MC ;
Puccetti, P .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 307 (02) :191-199